These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7901132)

  • 1. A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis.
    Renton RJ; Cowie JS; Oon MC
    Forensic Sci Int; 1993 Aug; 60(3):189-202. PubMed ID: 7901132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine.
    Bohn M; Bohn G; Blaschke G
    Int J Legal Med; 1993; 106(1):19-23. PubMed ID: 8104465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA).
    Noggle FT; Clark CR; Andurkar S; DeRuiter J
    J Chromatogr Sci; 1991 Mar; 29(3):103-6. PubMed ID: 1676403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotopic characterisation of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethylamphetamine (ecstasy).
    Carter JF; Titterton aE; Murray M; Sleeman R
    Analyst; 2002 Jun; 127(6):830-3. PubMed ID: 12146919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MDMA ("ecstasy"): a currently used drug in Spain].
    Prat A; Montero M; Reig R; Sanz P
    Rev Clin Esp; 1991 Feb; 188(2):106-8. PubMed ID: 1675014
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the identification of psychotropic substances (VII). Preparation and various analytical data of standard references of some hallucinogens, 3,4-methylenedioxyamphetamine (MDA), 3,4- methylenedioxymethamphetamine (MDMA) and 5-methoxy-3,4- methylenedioxyamphetamine (MMDA)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1990; (108):118-25. PubMed ID: 1364339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study.
    Dams R; De Letter EA; Mortier KA; Cordonnier JA; Lambert WE; Piette MH; Van Calenbergh S; De Leenheer AP
    J Anal Toxicol; 2003; 27(5):318-22. PubMed ID: 12908947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of designer drugs in human hair by ion mobility spectrometry (IMS).
    Keller T; Miki A; Regenscheit P; Dirnhofer R; Schneider A; Tsuchihashi H
    Forensic Sci Int; 1998 Jun; 94(1-2):55-63. PubMed ID: 9670484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol.
    Heather E; Shimmon R; McDonagh AM
    Forensic Sci Int; 2015 Mar; 248():140-7. PubMed ID: 25617761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Kronstrand R
    J Anal Toxicol; 1996 Oct; 20(6):512-6. PubMed ID: 8889691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives.
    Forrest AR; Galloway JH; Marsh ID; Strachan GA; Clark JC
    Forensic Sci Int; 1994 Jan; 64(1):57-9. PubMed ID: 7908887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
    Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP
    Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of paramethoxyamphetamine and other amphetamine-related designer drugs by liquid chromatography/sonic spray ionization mass spectrometry.
    Mortier KA; Dams R; Lambert WE; De Letter EA; Van Calenbergh S; De Leenheer AP
    Rapid Commun Mass Spectrom; 2002; 16(9):865-70. PubMed ID: 11948818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry.
    Kikura-Hanajiri R; Kawamura M; Miyajima A; Sunouchi M; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):62-9. PubMed ID: 20299167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designer drug confusion: a focus on MDMA.
    Beck J; Morgan PA
    J Drug Educ; 1986; 16(3):287-302. PubMed ID: 2877058
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens.
    Liu RH; Liu HC; Lin DL
    J Anal Toxicol; 2006 Oct; 30(8):545-50. PubMed ID: 17132249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flashbacks following MDMA.
    McGuire P; Fahy T
    Br J Psychiatry; 1992 Feb; 160():276. PubMed ID: 1347241
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats.
    Yousif MY; Fitzgerald RL; Narasimhachari N; Rosecrans JA; Blanke RV; Glennon RA
    Drug Alcohol Depend; 1990 Oct; 26(2):127-35. PubMed ID: 1978707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of MDMA/MDA in both hair and urine in drug users.
    Han E; Yang W; Lee J; Park Y; Kim E; Lim M; Chung H
    Forensic Sci Int; 2005 Aug; 152(1):73-7. PubMed ID: 15939177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.